Design and protocol of a comprehensive multicentre biobank for abdominal aortic aneurysms.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 08 2019
Historique:
entrez: 4 8 2019
pubmed: 4 8 2019
medline: 2 9 2020
Statut: epublish

Résumé

The pathophysiology and natural course of abdominal aortic aneurysms (AAAs) are insufficiently understood. In order to improve our understanding, it is imperative to carry out longitudinal research that combines biomarkers with clinical and imaging data measured over multiple time points. Therefore, a multicentre biobank, databank and imagebank has been established in the Netherlands: the ' The AAA bank is a prospective multicentre observational biobank, databank and imagebank of patients with an AAA. It is embedded within the framework of the Parelsnoer Institute, which facilitates uniform biobanking in all university medical centres (UMCs) in the Netherlands. The AAA bank has been initiated by the two UMCs of Amsterdam UMC and by Leiden University Medical Center. Participants will be followed during AAA follow-up. Clinical data are collected every patient contact. Three types of biomaterials are collected at baseline and during follow-up: blood (including DNA and RNA), urine and AAA tissue if open surgical repair is performed. Imaging data that are obtained as part of clinical care are stored in the imagebank. All data and biomaterials are processed and stored in a standardised manner. AAA growth will be based on multiple measurements and will be analysed with a repeated measures analysis. Potential associations between AAA growth and risk factors that are also measured on multiple time points can be assessed with multivariable mixed-effects models, while potential associations between AAA rupture and risk factors can be tested with a conditional dynamic prediction model with landmarking or with joint models in which linear mixed-effects models are combined with Cox regression. The AAA bank is approved by the Medical Ethics Board of the Amsterdam UMC (University of Amsterdam). NCT03320408.

Identifiants

pubmed: 31375618
pii: bmjopen-2018-028858
doi: 10.1136/bmjopen-2018-028858
pmc: PMC6688677
doi:

Substances chimiques

Biomarkers 0

Banques de données

ClinicalTrials.gov
['NCT03320408']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028858

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Public Health. 2012 Nov 06;12:949
pubmed: 23130988
Neuroinformatics. 2007 Spring;5(1):11-34
pubmed: 17426351
Int J Stroke. 2015 Jan;10(1):120-2
pubmed: 25131301
Curr Med Res Opin. 2016;32(3):509-17
pubmed: 26636178
Ann Surg. 1999 Sep;230(3):289-96; discussion 296-7
pubmed: 10493476
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
J Vasc Surg. 2018 Jan;67(1):2-77.e2
pubmed: 29268916
Pancreas. 2018 Apr;47(4):495-501
pubmed: 29521943
Circulation. 2011 Sep 6;124(10):1118-23
pubmed: 21844079
Nat Rev Cardiol. 2011 Feb;8(2):92-102
pubmed: 21079638
Eur J Vasc Endovasc Surg. 2016 Oct;52(4):475-486
pubmed: 27558090
Eur J Vasc Endovasc Surg. 2016 Sep;52(3):333-42
pubmed: 27283346
Nat Rev Cardiol. 2009 Jul;6(7):464-74
pubmed: 19468292
Br J Surg. 2014 Oct;101(11):1358-72
pubmed: 25131707
BMC Neurol. 2014 Dec 31;14:254
pubmed: 25551191
Ned Tijdschr Geneeskd. 2009;153:A572
pubmed: 20051151
J Law Med Ethics. 2016 Mar;44(1):68-84
pubmed: 27256125
Br J Surg. 2013 Oct;100(11):1405-13
pubmed: 24037558
Br J Surg. 2018 Jan;105(1):68-74
pubmed: 29265406
Summit Transl Bioinform. 2008 Mar 01;2008:110-4
pubmed: 21347130

Auteurs

Hamid Jalalzadeh (H)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Reza Indrakusuma (R)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Jan D Blankensteijn (JD)

Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Willem Wisselink (W)

Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Kak K Yeung (KK)

Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Jan H N Lindeman (JHN)

Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Jaap F Hamming (JF)

Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Mark J W Koelemay (MJW)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Dink A Legemate (DA)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Ron Balm (R)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH